Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,024 | 201 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $841.36 | 42 | $0 (2022) |
| Esperion Therapeutics, Inc. | $416.74 | 19 | $0 (2022) |
| GlaxoSmithKline, LLC. | $376.26 | 17 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $357.29 | 16 | $0 (2022) |
| Novo Nordisk Inc | $325.75 | 16 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $284.40 | 5 | $0 (2022) |
| Scilex Pharmaceuticals Inc. | $219.59 | 10 | $0 (2022) |
| Amarin Pharma Inc. | $149.39 | 11 | $0 (2022) |
| PFIZER INC. | $114.35 | 8 | $0 (2021) |
| UCB, Inc. | $102.97 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.74 | 1 | Novo Nordisk Inc ($13.74) |
| 2022 | $1,042 | 56 | ABBVIE INC. ($354.46) |
| 2021 | $1,763 | 93 | AbbVie Inc. ($438.35) |
| 2020 | $1,206 | 51 | AstraZeneca Pharmaceuticals LP ($223.11) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Diabetes | ||||||
| 09/21/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/17/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/07/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/22/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Diabetes | ||||||
| 05/23/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Cardiovascular | ||||||
| 05/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $114.85 | General |
| Category: Cardio-renal | ||||||
| 05/17/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Respiratory | ||||||
| 05/16/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Diabetes Care | ||||||
| 05/11/2022 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/10/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Neuroscience | ||||||
| 05/03/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardio-renal | ||||||
| 04/26/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: DIABETES | ||||||
| 04/20/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 57 | 69 | $10,398 | $3,839 |
| 2021 | 6 | 129 | 167 | $21,261 | $9,504 |
| 2020 | 4 | 127 | 157 | $18,148 | $8,918 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 36 | $6,372 | $2,619 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 33 | $4,026 | $1,219 | 30.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 63 | $11,033 | $4,535 | 41.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 44 | $5,242 | $1,929 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 14 | 14 | $2,968 | $1,908 | 64.3% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 12 | 12 | $1,308 | $967.12 | 73.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 18 | $630.00 | $128.02 | 20.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 12 | 16 | $80.00 | $36.00 | 45.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 80 | 105 | $12,480 | $6,041 | 48.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $2,800 | $1,280 | 45.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 14 | $2,450 | $1,262 | 51.5% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2020 | 19 | 22 | $418.00 | $334.95 | 80.1% |
About Dr. Amitha Parvataneni, MD
Dr. Amitha Parvataneni, MD is a Family Medicine healthcare provider based in Saint Clair Shores, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1336326362.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amitha Parvataneni, MD has received a total of $4,024 in payments from pharmaceutical and medical device companies, with $13.74 received in 2024. These payments were reported across 201 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,024).
As a Medicare-enrolled provider, Parvataneni has provided services to 313 Medicare beneficiaries, totaling 393 services with total Medicare billing of $22,261. Data is available for 3 years (2020–2022), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Saint Clair Shores, MI
- Active Since 01/22/2008
- Last Updated 11/07/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1336326362
Products in Payments
- UBRELVY (Drug) $432.01
- TRELEGY ELLIPTA (Drug) $319.12
- NEXLETOL (Drug) $295.17
- Kerendia (Drug) $284.40
- VRAYLAR (Drug) $233.32
- Ozempic (Drug) $224.66
- ZTLido (Drug) $173.48
- BREZTRI AEROSPHERE (Drug) $152.91
- Vascepa (Drug) $149.39
- NEXLIZET (Drug) $121.57
- LINZESS (Drug) $108.69
- CREON (Drug) $91.85
- ENTRESTO (Drug) $78.33
- Aimovig (Biological) $72.66
- BREZTRI (Drug) $68.76
- FARXIGA (Drug) $62.43
- REXULTI (Drug) $60.32
- ANORO ELLIPTA (Drug) $57.14
- COLOGUARD (Device) $56.33
- Vimpat (Drug) $53.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Saint Clair Shores
Mark Alrais, M.d, M.D
Family Medicine — Payments: $5,993
Dr. Tihomir Mihaylov, Md, MD
Family Medicine — Payments: $5,468
Keith Hoffmann, Md, MD
Family Medicine — Payments: $5,311
Mrs. Flora Smith, Np, NP
Family Medicine — Payments: $4,719
David Larose, Md, MD
Family Medicine — Payments: $2,554
Rachel Young, D.o, D.O
Family Medicine — Payments: $2,399